Vivus Says FDA Asks About Qnexa Birth Defect Link

From Associated Press (January 21, 2011)
MOUNTAIN VIEW, Calif. -- Shares of the drug company Vivus Inc.
slumped 15 percent before the market opened Friday on concerns over
the potential side effects of its obesity drug candidate.
The Food and...